BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mišak Z, Hojsak I, Homan M. Review: Helicobacter pylori in pediatrics. Helicobacter 2019;24 Suppl 1:e12639. [PMID: 31486243 DOI: 10.1111/hel.12639] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Kakiuchi T, Takamori A, Matsuo M. High Prevalence of Helicobacter pylori Infection in Special Needs Schools in Japan. Front Pediatr 2021;9:697200. [PMID: 34307259 DOI: 10.3389/fped.2021.697200] [Reference Citation Analysis]
2 Kakiuchi T, Tanaka Y, Ohno H, Matsuo M, Fujimoto K. Helicobacter pylori infection-induced changes in the intestinal microbiota of 14-year-old or 15-year-old Japanese adolescents: a cross-sectional study. BMJ Open 2021;11:e047941. [PMID: 34215607 DOI: 10.1136/bmjopen-2020-047941] [Reference Citation Analysis]
3 Peng C, Hu Y, Ge ZM, Zou QM, Lyu NH. Diagnosis and treatment of Helicobacter pylori infections in children and elderly populations. Chronic Dis Transl Med 2019;5:243-51. [PMID: 32055783 DOI: 10.1016/j.cdtm.2019.12.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
4 Mărginean CO, Meliț LE, Săsăran MO. Gastric Microenvironment-A Partnership between Innate Immunity and Gastric Microbiota Tricks Helicobacter pylori. J Clin Med 2021;10:3258. [PMID: 34362042 DOI: 10.3390/jcm10153258] [Reference Citation Analysis]
5 Meliț LE, Mărginean CO, Săsăran MO, Mocan S, Ghiga DV, Bogliş A, Duicu C. Innate immunity – the hallmark of Helicobacter pylori infection in pediatric chronic gastritis. World J Clin Cases 2021; 9(23): 6686-6697 [PMID: 34447815 DOI: 10.12998/wjcc.v9.i23.6686] [Reference Citation Analysis]
6 Kakiuchi T, Matsuo M, Endo H, Sakata Y, Esaki M, Noda T, Imamura I, Hashiguchi K, Ogata S, Fujioka Y, Hanada K, Fukuda K, Yoshimura M, Kajiwara T, Yamamoto K, Yamaguchi D, Kawakubo H, Akashi T, Sumino M, Matsunaga K, Muro E, Kuwahara A, Taniguchi K, Fukuyama K, Watanabe A, Takamori A, Okuda M, Yamanouchi K, Fujimoto K. Gastrointestinal adverse reactions reduce the success rate of Helicobacter pylori eradication therapy: A multicenter prospective cohort study. Helicobacter 2021;26:e12776. [PMID: 33368891 DOI: 10.1111/hel.12776] [Reference Citation Analysis]